Since the introduction of DPP4 inhibitors as a promising therapy for type 2 diabetes mellitus patients, the relevance of DPP4 has grown significantly in the scientific and medical communities [1–3]. This evidence concerns the gene DPP4 and type 2 diabetes mellitus.